1. Home
  2. ASMB vs SHMD Comparison

ASMB vs SHMD Comparison

Compare ASMB & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • SHMD
  • Stock Information
  • Founded
  • ASMB 2005
  • SHMD 1864
  • Country
  • ASMB United States
  • SHMD Germany
  • Employees
  • ASMB N/A
  • SHMD N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • SHMD
  • Sector
  • ASMB Health Care
  • SHMD
  • Exchange
  • ASMB Nasdaq
  • SHMD Nasdaq
  • Market Cap
  • ASMB 84.5M
  • SHMD 86.1M
  • IPO Year
  • ASMB 2010
  • SHMD N/A
  • Fundamental
  • Price
  • ASMB $13.30
  • SHMD $2.26
  • Analyst Decision
  • ASMB Buy
  • SHMD
  • Analyst Count
  • ASMB 2
  • SHMD 0
  • Target Price
  • ASMB $35.00
  • SHMD N/A
  • AVG Volume (30 Days)
  • ASMB 22.6K
  • SHMD 57.1K
  • Earning Date
  • ASMB 03-27-2025
  • SHMD 02-25-2025
  • Dividend Yield
  • ASMB N/A
  • SHMD N/A
  • EPS Growth
  • ASMB N/A
  • SHMD 1309.32
  • EPS
  • ASMB N/A
  • SHMD 1.07
  • Revenue
  • ASMB $28,326,000.00
  • SHMD $99,752,404.00
  • Revenue This Year
  • ASMB $282.16
  • SHMD N/A
  • Revenue Next Year
  • ASMB N/A
  • SHMD N/A
  • P/E Ratio
  • ASMB N/A
  • SHMD $2.11
  • Revenue Growth
  • ASMB N/A
  • SHMD N/A
  • 52 Week Low
  • ASMB $11.01
  • SHMD $1.86
  • 52 Week High
  • ASMB $19.93
  • SHMD $6.13
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 38.89
  • SHMD N/A
  • Support Level
  • ASMB $13.13
  • SHMD N/A
  • Resistance Level
  • ASMB $14.25
  • SHMD N/A
  • Average True Range (ATR)
  • ASMB 0.55
  • SHMD 0.00
  • MACD
  • ASMB -0.07
  • SHMD 0.00
  • Stochastic Oscillator
  • ASMB 15.38
  • SHMD 0.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: